Deep, qualified future-technology sequencing has discovered that subclonal mutations (i.e., Those people present in only a fraction of tumor cells) is often detected for all driver genes and are linked to speedy sickness progression and lousy outcome.eleven–13 This is particularly suitable for TP53Duvelisib was the second PI3K inhibitor approved